PRME vs. HIMS
PRME (Prime Medicine Inc. Common Stock) and HIMS (Hims & Hers Health, Inc.) are both stocks. Both are in the Healthcare sector — PRME in Biotechnology, HIMS in Drug Manufacturers - Specialty & Generic. Over the past 3 years, PRME returned -40.75%/yr vs 57.19%/yr for HIMS. At a 0.31 correlation, their price movements are largely independent.
Performance
PRME vs. HIMS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PRME achieves a -10.09% return, which is significantly lower than HIMS's 0.71% return.
PRME
- 1D
- -3.70%
- 1M
- 5.05%
- YTD
- -10.09%
- 6M
- -12.61%
- 1Y
- 26.83%
- 3Y*
- -40.75%
- 5Y*
- —
- 10Y*
- —
HIMS
- 1D
- -0.79%
- 1M
- 37.68%
- YTD
- 0.71%
- 6M
- -5.68%
- 1Y
- -23.86%
- 3Y*
- 57.19%
- 5Y*
- 25.15%
- 10Y*
- —
PRME vs. HIMS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
PRME Prime Medicine Inc. Common Stock | -10.09% | 18.84% | -67.04% | -52.31% | -2.06% |
HIMS Hims & Hers Health, Inc. | 0.71% | 34.28% | 171.69% | 38.85% | 56.72% |
Correlation
The correlation between PRME and HIMS is 0.37, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.37 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.34 |
Correlation (All Time) Calculated using the full available price history since Oct 20, 2022 | 0.31 |
Fundamentals
PRME:
$552.54M
HIMS:
$7.47B
PRME:
-$1.29
HIMS:
-$0.05
PRME:
151.08
HIMS:
3.39
PRME:
7.20
HIMS:
16.74
PRME:
$3.18M
HIMS:
$2.37B
PRME:
-$4.14M
HIMS:
$1.70B
PRME:
-$195.72M
HIMS:
$16.04M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PRME vs. HIMS — Risk / Return Rank
PRME
HIMS
PRME vs. HIMS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Prime Medicine Inc. Common Stock (PRME) and Hims & Hers Health, Inc. (HIMS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PRME | HIMS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.55 | ||
| Sortino ratioReturn per unit of downside risk | +0.96 | ||
| Omega ratioGain probability vs. loss probability | 1.12 | 1.02 | +0.10 |
| Calmar ratioReturn relative to maximum drawdown | 0.45 | -0.31 | +0.76 |
| Martin ratioReturn relative to average drawdown | 0.70 | -0.50 | +1.20 |
Loading charts...
Drawdowns
PRME vs. HIMS - Drawdown Comparison
The maximum PRME drawdown since its inception was -94.55%, which is greater than HIMS's maximum drawdown of -87.29%. Use the drawdown chart below to compare losses from any high point for PRME and HIMS.
Loading charts...
Drawdown Indicators
| PRME | HIMS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.55% | -87.29% | -7.26% |
Max Drawdown (1Y)Largest decline over 1 year | -59.52% | -78.06% | +18.54% |
Max Drawdown (3Y)Largest decline over 3 years | -92.37% | -78.88% | -13.49% |
Max Drawdown (5Y)Largest decline over 5 years | — | -78.88% | — |
Current DrawdownCurrent decline from peak | -85.23% | -52.43% | -32.80% |
Average DrawdownAverage peak-to-trough decline | -65.66% | -43.27% | -22.39% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 38.30% | 48.25% | -9.95% |
Volatility
PRME vs. HIMS - Volatility Comparison
Prime Medicine Inc. Common Stock (PRME) has a higher volatility of 26.95% compared to Hims & Hers Health, Inc. (HIMS) at 23.47%. This indicates that PRME's price experiences larger fluctuations and is considered to be riskier than HIMS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PRME | HIMS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 26.95% | 23.47% | +3.48% |
Volatility (6M)Calculated over the trailing 6-month period | 54.02% | 69.20% | -15.18% |
Volatility (1Y)Calculated over the trailing 1-year period | 95.98% | 91.29% | +4.69% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 90.32% | 83.56% | +6.76% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 90.32% | 77.35% | +12.97% |
Dividends
PRME vs. HIMS - Dividend Comparison
Neither PRME nor HIMS has paid dividends to shareholders.
Financials
PRME vs. HIMS - Financials Comparison
This section allows you to compare key financial metrics between Prime Medicine Inc. Common Stock and Hims & Hers Health, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
PRME and HIMS have a correlation of 0.37, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PRME has higher volatility (26.95%) compared to HIMS (23.47%). In terms of maximum drawdown, PRME dropped -94.55% vs HIMS's -87.29%.
PRME currently has the higher Sharpe Ratio (0.28 vs -0.26), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PRME and HIMS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer